There is no evidence that semaglutide affects acid-base balance, but patients on combination therapy should have their bicarbonate levels monitored, particularly if they have kidney disease or are taking other medications that affect acid-base status
In a 48-week phase 2 trial of people with obesity or overweight and one weight-related comorbidity without type 2 diabetes, the mean percent weight change was 7.3%, 10.5%, 13.8%, 17.5%, with weekly eloralintide 1 mg, 3 mg, 6 mg, and 9 mg, respectively, compared to 2.3% with placebo (Table 1) [40]
Finally, residual confounding cannot be excluded
The first milestones in the case will be selecting lead counsel, filing a master complaint, and establishing a preliminary discovery schedule for document production
At Vermont Med Spa, we strive to offer effective, personalized weight loss solutions, including Semaglutide (the active ingredient in Ozempic and Wegovy) as part of our medically supervised weight management programs